Work

High (95%) Response Rates in Relapsed/Refractory Mantle Cell Lymphoma after R-HCVAD Alternating with R-Methotrexate/Cytarabine (R-M-A).

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.2446.2446

Authors: Jorge Enrique Romaguera, Luis E. Fayad, Michael Wang, Fernando Cabanillas, Fredrick Hagemeister, Peter McLaughlin, Alma Rodriguez, Anas Younes, Sattva Neelapu, Andre H. Goy, Virginia Beasley, Larry Kwak

Institutions: The University of Texas MD Anderson Cancer Center, Auxilio Mutuo Hospital, Hackensack University Medical Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2561654297

FWCI: 0.444

Cites:

Cited by: 3

Related to: 10